Susquehanna International Group, LLP Black Diamond Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.2 - $6.58 $221,760 - $347,424	52,800 Added 298.31%	70,500 $306,000
Q2 2024 Aug 15, 2024	BUY	$4.65 - $7.39 $82,305 - $130,803	17,700 New	17,700 $82,000
Q3 2023 Nov 14, 2023	SELL	$2.87 - $4.99 $50,799 - $88,323	-17,700 Reduced 40.32%	26,200 $75,000
Q2 2023 Aug 11, 2023	BUY	$1.43 - $6.18 $62,777 - $271,302	43,900 New	43,900 $221,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $12,768 - $30,476	-7,600 Reduced 8.45%	82,300 $139,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $95.9M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.